37
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Transcatheter aortic valve replacement: the changing paradigm of aortic stenosis treatment

, &
Pages 1127-1135 | Published online: 10 Jan 2014

References

  • Brown JM, O’Brien SM, Wu C et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg.137(1), 82–90 (2009).
  • Bramstedt KA. Aortic valve replacement in the elderly: frequently indicated yet frequently denied. Gerontology49(1), 46–49 (2003).
  • Brown ML, Schaff HV, Sarano ME et al. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J. Thorac. Cardiovasc. Surg.136(3), 566–571 (2008).
  • Dewey TM, Brown D, Ryan WH et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J. Thorac. Cardiovasc. Surg.135(1), 180–187 (2008).
  • Thourani VH, Ailawadi G, Szeto WY et al. Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann. Thorac. Surg.91(1), 49–55; discussion 55–56 (2011).
  • Piazza N, Wenaweser P, van Gameren M et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons predicted risk of mortality score in patients implanted with the CoreValve ReValving system – a Bern-Rotterdam Study. Am. Heart J.159(2), 323–329 (2010).
  • Smith C. Valvular heart disease. J. Am. Coll. Cardiol.53, A403–A418 (2009).
  • Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation121(8), 973–978 (2010).
  • Afilalo J, Eisenberg MJ, Morin JF et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J. Am. Coll. Cardiol.56(20), 1668–1676 (2010).
  • Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation123(3), 299–308 (2011).
  • Zahn R, Gerckens U, Grube E et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur. Heart J.32(2), 198–204 (2011).
  • Hutter A, Opitz A, Bleiziffer S et al. Aortic annulus evaluation in transcatheter aortic valve implantation. Catheter Cardiovasc. Interv.76(7), 1009–1019 (2010).
  • Babaliaros VC, Liff D, Chen EP et al. Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? JACC Cardiovasc. Interv.1(5), 580–586 (2008).
  • Leipsic J, Gurvitch R, Labounty TM et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc. Imaging4(4), 416–429 (2011).
  • Babaliaros VC, Junagadhwalla Z, Lerakis S et al. Use of balloon aortic valvuloplasty to size the aortic annulus before implantation of a balloon-expandable transcatheter heart valve. JACC Cardiovasc. Interv.3(1), 114–118 (2010).
  • Latib A, Michev I, Laborde JC, Montorfano M, Colombo A. Post-implantation repositioning of the CoreValve percutaneous aortic valve. JACC Cardiovasc. Interv.3(1), 119–121 (2010).
  • Vavuranakis M, Vrachatis D, Stefanadis C. CoreValve aortic bioprosthesis: repositioning techniques. JACC Cardiovasc. Interv.3(5), 565; author reply 565–566 (2010).
  • Tzikas A, Schultz C, Van Mieghem NM, de Jaegere PP, Serruys PW. Optimal projection estimation for transcatheter aortic valve implantation based on contrast-aortography: validation of a Prototype Software. Catheter Cardiovasc. Interv.76(4), 602–607 (2010).
  • Kahlert P, Eggebrecht H, Plicht B et al. Towards real-time cardiovascular magnetic resonance-guided transarterial aortic valve implantation: in vitro evaluation and modification of existing devices. J. Cardiovasc. Magn. Reson.12, 58 (2010).
  • Rosengart TK, Feldman T, Borger MA et al. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation117(13), 1750–1767 (2008).
  • Ruiz CE, Feldman TE, Hijazi ZM et al. Interventional fellowship in structural and congenital heart disease for adults. JACC Cardiovasc. Interv.3(9), e1–e15 (2010).
  • Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am. Heart J.159(5), 926–932 (2010).
  • Bauer F, Lemercier M, Zajarias A, Tron C, Eltchaninoff H, Cribier A. Immediate and long-term echocardiographic findings after transcatheter aortic valve implantation for the treatment of aortic stenosis: the Cribier-Edwards/Edwards-Sapien valve experience. J. Am. Soc. Echocardiogr.23(4), 370–376 (2010).
  • Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J. Am. Coll. Cardiol.53(20), 1829–1836 (2009).
  • Clavel MA, Webb JG, Pibarot P et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J. Am. Coll. Cardiol.53(20), 1883–1891 (2009).
  • Clavel MA, Webb JG, Rodés-Cabau J et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation122(19), 1928–1936 (2010).
  • Gotzmann M, Hehen T, Germing A et al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart96(14), 1102–1106 (2010).
  • Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med.363(17), 1597–1607 (2010).
  • Krane M, Deutsch MA, Bleiziffer S et al. Quality of life among patients undergoing transcatheter aortic valve implantation. Am. Heart J.160(3), 451–457 (2010).
  • Himbert D, Descoutures F, Al-Attar N et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J. Am. Coll. Cardiol.54(4), 303–311 (2009).
  • Coeytaux RR, Williams JW Jr, Gray RN, Wang A et al. Percutaneous heart valve replacement for aortic stenosis: state of the evidence. Ann. Intern. Med.153(5), 314–324 (2010).
  • Rodés-Cabau J, Webb JG, Cheung A et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol.55(11), 1080–1090 (2010).
  • Moynagh AM, Scott DJ, Baumbach A et al. CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach. J. Am. Coll. Cardiol.57(5), 634–635 (2011).
  • Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation121(7), 870–878 (2010).
  • Babaliaros VC. Front stroke, back stroke: the ‘emerging’ interest of stroke in transcatheter aortic valve implantation. JACC Cardiovasc. Interv.3(11), 1139–1140 (2010).
  • Astarci P, Glineur D, Kefer J et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur. J. Cardiothorac. Surg.40(2), 475–479 (2011).
  • Rodés-Cabau J, Dumont E, Boone RH et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J. Am. Coll. Cardiol.57(1), 18–28 (2011).
  • Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation122(1), 62–69 (2010).
  • Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv.3(11), 1133–1138 (2010).
  • Godin M, Eltchaninoff H, Furuta A et al. Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am. J. Cardiol.106(5), 707–712 (2010).
  • Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation123(9), 951–960 (2011).
  • Fraccaro C, Buja G, Tarantini G et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am. J. Cardiol.107(5), 747–754 (2011).
  • Bleiziffer S, Ruge H, Hörer J et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc. Interv.3(5), 524–530 (2010).
  • Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol.47(6), 1214–1223 (2006).
  • León C, Suárez de Lezo J, Mesa D et al. Early development of leaks in the CoreValve percutaneous aortic valve prosthesis: echocardiographic assessment. Rev. Esp. Cardiol.64(1), 67–70 (2011).
  • Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur. Heart J.32(2), 205–217 (2011).
  • Zoghbi WA, Chambers JB, Dumesnil JG et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr.22(9), 975–1014; quiz 1082–1084 (2009).
  • Détaint D, Lepage L, Himbert D et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc. Interv.2(9), 821–827 (2009).
  • Abdel-Wahab M, Zahn R, Horack M et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart97(11), 899–906 (2011).
  • Rajani R, Kakad M, Khawaja MZ et al. Paravalvular regurgitation one year after transcatheter aortic valve implantation. Catheter Cardiovasc. Interv.75(6), 868–872 (2010).
  • Sherif MA, Abdel-Wahab M, Stöcker B et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J. Am. Coll. Cardiol.56(20), 1623–1629 (2010).
  • Stabile E, Sorropago G, Cioppa A. Acute left main obstructions following TAVI. EuroIntervention6(1), 100–105 (2011).
  • Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc. Interv.71(5), 579–584 (2008).
  • Falk V, Schwammenthal EE, Kempfert J et al. New anatomically oriented transapical aortic valve implantation. Ann. Thorac. Surg.87(3), 925–926 (2009).
  • Treede H, Tübler T, Reichenspurner H et al. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J. Thorac. Cardiovasc. Surg.140(4), 897–903 (2010).
  • Lewin MB, Otto CM. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation111(7), 832–834 (2005).
  • Otto CM. Calcification of bicuspid aortic valves. Heart88(4), 321–322 (2002).
  • Zegdi R, Ciobotaru V, Noghin M et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J. Am. Coll. Cardiol.51(5), 579–584 (2008).
  • Wijesinghe N, Ye J, Rodés-Cabau J et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc. Interv.3(11), 1122–1125 (2010).
  • Webb JG, Wood DA, Ye J et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation121(16), 1848–1857 (2010).
  • Seiffert M, Franzen O, Conradi L et al. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc. Interv.76(4), 608–615 (2010).
  • Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc. Interv.70(5), 760–764 (2007).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.